enVVeno Medical Corporation
enVVeno Medical Corporation (NVNOW) Stock Overview
Explore enVVeno Medical Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
73.7M
P/E Ratio
-4.60
EPS (TTM)
$-1.90
ROE
-0.51%
NVNOW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of enVVeno Medical Corporation (NVNOW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.01.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.60 and a market capitalization of 73.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.